Key result
Postoperative hypocholesterolemia is linked to ~5-fold higher odds of major adverse events after valvular surgery.
Why the study?
Early postoperative low cholesterol levels associate with mortality and major complications after CABG, but whether this pattern extends to aortic or mitral valve surgery was unknown.
Does early postoperative hypocholesterolemia associate with 30-day mortality and major adverse outcomes in adults undergoing elective aortic or mitral valve surgery?
Cohort (n=2,105)
No
Does early postoperative hypocholesterolemia associate with 30-day mortality and major adverse outcomes in adults undergoing elective aortic or mitral valve surgery?
Early postoperative hypocholesterolemia during the first five days after elective aortic or mitral valve surgery is significantly associated with 30-day mortality and major postoperative complications, mirroring patterns seen in CABG patients.
Answers are grounded in this paper and cite their sources.
Postoperative hypocholesterolemia signals elevated adverse event risk after valve surgery; extends CABG observations but remains hypothesis-generating without randomized evidence.
Recently, we demonstrated that early postoperative low cholesterol levels associate with mortality and major complications after coronary artery bypass grafting (CABG). To assess whether this pattern extends to valve surgery, we analyzed adult patients undergoing elective aortic (AVS) or mitral valve surgery (MVS) between 2010 and 2023. The minimum cholesterol level during the first five postoperative days was evaluated both continuously and using outcome specific thresholds derived from Receiver Operating Characteristic (ROC) and Youden analysis. In 1326 AVS and 779 MVS patients, the minimum postoperative cholesterol was associated with adverse events, with area under curve (AUC) values of 0.697 (0.645–0.749) in AVS and 0.694 (0.633–0.756) in MVS. For 30-day mortality, cerebrovascular events (CVA), renal replacement therapy (RRT), and respiratory dysfunction, the corresponding thresholds showed significant associations with their respective outcomes (AUC 0.615–0.848; sensitivity 0.406–0.762; specificity 0.613–0.933), with unadjusted odds ratios ranging from 2.4 to 9.3 across primary endpoints (reaching up to 24.2 for CVA, which exhibited wide confidence intervals due to low event counts, all p < 0.05). Thresholds for the composite adverse outcome showed a consistent association in both AVS and MVS (AUC 0.694–0.697; sensitivity 0.476–0.494; specificity 0.840–0.847), providing an aggregated endpoint that complements the individual outcomes. These thresholds aligned with the same low cholesterol range observed in CABG, suggesting a potentially shared post-cardiotomy metabolic stress response across cardiac surgical populations that warrants further prospective investigation.
No takes yet. Share an insight, caveat, or question.
Haan et al. (2026) conducted a cohort in Elective aortic or mitral valve surgery (n=2,105). Early postoperative hypocholesterolemia (minimum total cholesterol ≤2.83 mmol/L in AVS; ≤2.86 mmol/L in MVS during postoperative days 1-5) vs. Normal postoperative cholesterol (>2.83 mmol/L in AVS; >2.86 mmol/L in MVS) was evaluated on Composite adverse outcome (30-day mortality, cerebrovascular accident, new-onset renal replacement therapy, or respiratory dysfunction) in aortic valve surgery cohort (OR 5.034, 95% CI 2.872-8.824, p=<0.001). Postoperative hypocholesterolemia increased composite adverse event odds after aortic and mitral valve surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: